Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Peripheral Nervous System Diseases 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1

Interventions

Acupuncture Therapy 3Paclitaxel 2Dexamethasone 2Cryotherapy 2Bortezomib 2XELOX 1Taxoids 1Sodium Selenite 1Sodium Chloride 1Silymarin 1Saline Solution 1Low-Level Light Therapy 1Glutamine 1G(M1) Ganglioside 1Folfox protocol 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1Amplified Fragment Length Polymorphism Analysis 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Peripheral Nervous System Diseases × G(M1) Ganglioside × Clear all
NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Sun Yat-sen University

Phase 2 Unknown
100 enrolled
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡